Rixin Chen

Papers

Total Citations

H-Index

About

Rixin Chen is a rising leader in thoracic surgical oncology, with a focused expertise in minimally invasive approaches for lung cancer. His research centers on comparing the effectiveness and patient-centered outcomes of robotic-assisted thoracoscopic surgery (RATS), video-assisted thoracoscopic surgery (VATS), and traditional open thoracotomy. Dr. Chen’s major contributions include a pivotal 2023 meta-analysis demonstrating that minimally invasive surgery is both safe and effective for non-small-cell lung cancer patients with N2 disease, a finding that has already garnered 12 citations and is shaping clinical decision-making for advanced-stage cases. He further advanced the field with a 2024 study on early patient-reported outcomes after robotic versus video-assisted lobectomy, providing crucial evidence that RATS may offer superior recovery experiences from the patient’s perspective—work that has earned 7 citations in under a year. By integrating traditional clinical endpoints with patient-reported measures, Dr. Chen is redefining how surgical success is evaluated. His work is highly cited for its immediate clinical relevance, and he is recognized for championing a more holistic, patient-first approach to thoracic surgery.